Provided by Tiger Fintech (Singapore) Pte. Ltd.

TransMedics Group, Inc.

107.29
-5.6900-5.04%
Post-market: 106.50-0.7900-0.74%19:59 EDT
Volume:1.01M
Turnover:110.42M
Market Cap:3.66B
PE:53.17
High:114.00
Open:113.54
Low:107.22
Close:112.98
52wk High:145.50
52wk Low:55.00
Shares:34.09M
Float Shares:32.95M
Volume Ratio:1.04
T/O Rate:3.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.02
EPS(LYR):1.07
ROE:28.21%
ROA:5.80%
PB:11.50
PE(LYR):100.53

Loading ...

Oct 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
May 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 23, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Feb 21, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 10, 2024

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2024

Proposed Sale Of Securities

Form 144 | TransMedics Group, Inc.'s Officer Tamer Khayal proposes to sell 7625 shares, with a total value of approximately $625,021.
Oct 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]